Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEBRIKIZUMAB Cause Treatment failure? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Treatment failure have been filed in association with LEBRIKIZUMAB (EBGLYSS). This represents 11.5% of all adverse event reports for LEBRIKIZUMAB.

9
Reports of Treatment failure with LEBRIKIZUMAB
11.5%
of all LEBRIKIZUMAB reports
0
Deaths
9
Hospitalizations

How Dangerous Is Treatment failure From LEBRIKIZUMAB?

Of the 9 reports, 9 (100.0%) required hospitalization.

Is Treatment failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEBRIKIZUMAB. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does LEBRIKIZUMAB Cause?

Conjunctivitis (8) Asthma (7) Erythema (6)

What Other Drugs Cause Treatment failure?

METHOTREXATE (14,672) ETANERCEPT (11,893) ADALIMUMAB (9,990) ABATACEPT (9,301) RITUXIMAB (9,217) TOCILIZUMAB (9,097) HYDROXYCHLOROQUINE (8,786) LEFLUNOMIDE (8,686) INFLIXIMAB (8,535) SULFASALAZINE (7,423)

Related Pages

LEBRIKIZUMAB Full Profile All Treatment failure Reports All Drugs Causing Treatment failure LEBRIKIZUMAB Demographics